Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners

Edinburgh, Scotland and Newtown, PA, U.S.A, February 25, 2013 -- Quotient Biodiagnostics (“Quotient”), a global transfusion diagnostics group, is pleased to announce that its shareholders have invested a further $5.0 million in the company.  Over the past 18 months Quotient has raised over $19 million of new equity.

Get Answers Here